IGM Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 E Middlefield Road, Mountain View, California

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jakob Haldor Topsoe Director, 10%+ Owner $79.4 M Jun 28, 2024
Redmile Group, LLC Director, 10%+ Owner $70.8 M Jun 28, 2024
Holding A/S Topsoe 10%+ Owner $40.4 M Jun 26, 2023
Baker Bros. Advisors Lp Director, 10%+ Owner $28.5 M +$6.86 M +31.7% Jun 28, 2024
Fred Schwarzer CEO AND PRESIDENT, Director $3.41 M -$229 K -6.3% Jun 14, 2024
Bruce Keyt Chief Scientific Officer $1.53 M -$96.4 K -5.93% Jun 14, 2024
Daniel ShinYu Chen Chief Medical Officer $769 K Jul 1, 2021
Chris H. Takimoto Chief Medical Officer $726 K -$73.5 K -9.2% Jun 14, 2024
Lisa Lynn Decker Chief Business Officer $703 K -$73.8 K -9.5% Jun 14, 2024
Misbah Tahir Chief Financial Officer $673 K -$73.1 K -9.8% Jun 14, 2024
Mary Beth Harler Head, Research & Autoimmunity $646 K -$11.9 K -1.81% Jun 14, 2024
Christina Teng Topsoe Director, 10%+ Owner $425 K Jun 28, 2024
M. Kathleen Behrens Director $325 K Jun 28, 2024
George Gauthier Chief Commercial Officer $262 K -$14.8 K -5.34% Nov 29, 2023
Michael D. Loberg Director $231 K Sep 29, 2023
Steven Weber Principal Accounting Officer $197 K -$13.7 K -6.5% Jun 14, 2024
Michael Lee Director $57.5 K Jun 28, 2024
Elizabeth H.Z. Thompson Director $22 K Jun 28, 2024
William Strohl Director Mar 12, 2024
Julie Hambleton Director Mar 12, 2024

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership